In a recent BMJ report, Van Brabandt and colleagues present
their assessment of cardiovascular (CV) screening in athletes to prevent sudden
cardiac death (SCD) from the perspective of a health economist.
The authors make
several points of which we agree:
1) the diagnostic yield of CV screening by history and
physical examination alone is extremely low and with little supporting
evidence;
2) national, universal screening should not be mandated,
especially without appropriate physician infrastructure;
3) CV screening will detect disorders associated with SCD
but with an unclear absolute risk of CV events; and
4) the potential benefits and harms of different CV
screening programs are not fully understood.
However, we disagree with their conclusion, “As long as
those at high risk of sudden death cannot reliably be identified and
appropriately managed, young athletes should not be submitted to
pre-participation screening.” We wish to share a different perspective on why early
detection of CV disorders in athletes is both justified and can save lives.
Purpose and Assumptions
The premise of CV screening in athletes is that early
detection of cardiac disorders associated with SCD has the potential to reduce
morbidity and mortality through individualized and evidence-driven
disease-specific management. Without this belief, then screening by any
strategy is called into question. If one believes in early detection, screening
by history and physical examination alone is inadequate. The addition of ECG,
while still imperfect, will increase detection of disorders at elevated risk of
SCD and can be achieved with a low false-positive rate and high quality when
proper infrastructure and skilled cardiology resources are available.
No comments:
Post a Comment